DTIL
PRECISIO BIO (DTIL)
NASDAQ
$6.18+$0.14 (+2.30%)
Price as of Jun 03, 2026 7:57 PM EDT
  • $179.8M
    Market Cap
  • 22.72%
    1-Year Change
  • Biotechnology
    Industry

Top Holders

Institutional
Mutual Funds
Holder
Ownership %
Shares Held
Change (Shares, %)
Report Date
CVI HOLDINGS, LLC
33.14%
4.3M
+4.3M (+100.00%)
Jun 30, 2022
OCTAGON CAPITAL ADVISORS LP
17.44%
2.2M
+318,737 (+14.25%)
Mar 31, 2026
ABRDN PLC
17.39%
2.2M
+91,575 (+4.11%)
Mar 31, 2026
EMPERY ASSET MANAGEMENT, LP
15.35%
2.0M
-225,756 (-11.47%)
Mar 31, 2026
BLEICHROEDER LP
12.96%
1.7M
0 (0.00%)
Mar 31, 2026
OUP MANAGEMENT CO., LLC
8.76%
1.1M
0 (0.00%)
Sep 30, 2023
COWEN INC.
8.45%
1.1M
+75,361 (+6.95%)
Jun 30, 2019

Current Ownership Distribution

  • Institutions437.4M (66.65%)
  • Mutual Funds196.6M (29.96%)
  • Insiders22.2M (3.39%)
  • Other0 (0.00%)

Insider Transactions

  • 3.39% (22.2M)
    Current InsiderOwnership (%, shares)
  • 4
    Number of InsiderBuying (last 12 months)
  • $631,230.30
    Amount of InsiderBuying (last 12 months)
  • 4
    Number of InsiderSelling (last 12 months)
  • $4.0M
    Amount of InsiderSelling (last 12 months)
Insider Name & Title
Type
Date
Transaction Value
Shares
Share Price
Shares After Transactions
Kelly John Alexander
Chief Financial Officer
Award
Jun 01, 2026
$0.00
193,688
$0.00
193,688
Amoroso Michael
President and CEO
Award
Jun 01, 2026
$0.00
573,888
$0.00
573,888
Scimeca Dario
General Counsel and Secretary
Award
Jun 01, 2026
$0.00
107,604
$0.00
107,604
SMITH J. JEFFERSON
Chief Research Officer
Award
Jun 01, 2026
$0.00
57,389
$0.00
57,389
Brown Melinda
Exempt
May 20, 2026
$0.00
21,000
$0.00
0
Pire Shari Lisa
Exempt
May 20, 2026
$0.00
21,000
$0.00
0
Brown Melinda
Exempt
May 20, 2026
$0.00
21,000
$0.00
44,346
Pire Shari Lisa
Exempt
May 20, 2026
$0.00
21,000
$0.00
35,028
SMITH J. JEFFERSON
Chief Research Officer
Sell
Feb 18, 2026
$18,912.00
4,925
$3.84
121,926
Kelly John Alexander
Chief Financial Officer
Sell
Feb 18, 2026
$31,292.16
8,149
$3.84
125,883
Amoroso Michael
President and CEO
Sell
Feb 18, 2026
$78,946.56
20,559
$3.84
243,392
Scimeca Dario
General Counsel and Secretary
Sell
Feb 18, 2026
$18,912.00
4,925
$3.84
56,457
Kelly John Alexander
Chief Financial Officer
Exempt
Feb 17, 2026
$0.00
27,584
$0.00
55,166
SMITH J. JEFFERSON
Chief Research Officer
Exempt
Feb 17, 2026
$0.00
16,667
$0.00
33,333
Kelly John Alexander
Chief Financial Officer
Exempt
Feb 17, 2026
$0.00
27,584
$0.00
134,032
Amoroso Michael
President and CEO
Exempt
Feb 17, 2026
$0.00
67,797
$0.00
135,593
SMITH J. JEFFERSON
Chief Research Officer
Exempt
Feb 17, 2026
$0.00
16,667
$0.00
126,851
Scimeca Dario
General Counsel and Secretary
Exempt
Feb 17, 2026
$0.00
16,667
$0.00
33,333
Amoroso Michael
President and CEO
Exempt
Feb 17, 2026
$0.00
67,797
$0.00
263,951
Scimeca Dario
General Counsel and Secretary
Exempt
Feb 17, 2026
$0.00
16,667
$0.00
61,382
Amoroso Michael
President and CEO
Sell
Jan 22, 2026
$145,111.83
34,799
$4.17
196,154
Scimeca Dario
General Counsel and Secretary
Sell
Jan 21, 2026
$35,681.62
8,854
$4.03
44,715
Kelly John Alexander
Chief Financial Officer
Sell
Jan 21, 2026
$61,308.39
15,213
$4.03
106,448
SMITH J. JEFFERSON
Chief Research Officer
Exempt
Jan 21, 2026
$0.00
16,219
$0.00
120,384
SMITH J. JEFFERSON
Chief Research Officer
Sell
Jan 21, 2026
$41,106.00
10,200
$4.03
110,184
Amoroso Michael
President and CEO
Exempt
Jan 20, 2026
$0.00
8,888
$0.00
0
Scimeca Dario
General Counsel and Secretary
Exempt
Jan 20, 2026
$0.00
1,978
$0.00
0
Kelly John Alexander
Chief Financial Officer
Exempt
Jan 20, 2026
$0.00
3,888
$0.00
0
SMITH J. JEFFERSON
Chief Research Officer
Exempt
Jan 20, 2026
$0.00
2,500
$0.00
0
Amoroso Michael
President and CEO
Exempt
Jan 20, 2026
$0.00
37,069
$0.00
37,069